Cinacalcet recalls

Cinacalcet products have been recalled 17 times, most recently on 8 Jul 2026. The recalling company is usually Cipla USA. The most common reason is nitrosamine impurity.

Total recalls17since 2024

Last 12 months9reported

Class I00% of total

Ongoing13latest 8 Jul 2026

Recalls per month, last 24 months

click a bar for that month

6Nov '24 0 0 0Feb 0 0 0May 0 0 1Aug 0 0 0Nov 3 0 0Feb 0 3 0May 0 3 0Aug 0 0

Severity split

Class I 0 0%Class II 17 100%Class III 0 0%

Why cinacalcet is recalled

Companies

By year

2026635%
2025424%
2024741%

Ongoing cinacalcet recalls

13 active

Reported	Class	Recall	Company	Reason	Where
8 Jul 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 60 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
8 Jul 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 90 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
8 Jul 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 30 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
22 Apr 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 60 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
22 Apr 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 90 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
22 Apr 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 30 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide

All cinacalcet recalls, newest first

17 total

Reported	Class	Recall	Company	Reason	Where
8 Jul 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 60 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
8 Jul 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 90 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
8 Jul 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 30 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
22 Apr 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 60 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
22 Apr 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 90 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
22 Apr 2026Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 30 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
17 Dec 2025Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 60 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
17 Dec 2025Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 30 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
17 Dec 2025Drug	CLASS II	Cinacalcet Hydrochloride Tablets, 90 mg recalled by Cipla USACinacalcet	Cipla USA	Nitrosamine Impurity	Nationwide
6 Aug 2025Drug	CLASS II	Cinacalcet Tablets 90 mg recalled by Strides PharmaCinacalcet	Strides Pharma	Potency & Assay	Nationwide
6 Nov 2024Drug	CLASS II	Cinacalcet Tablets, 30 mg recalled by Dr. Reddy's LaboratoriesCinacalcet	Dr. Reddy's Laboratories	Nitrosamine Impurity	Nationwide
6 Nov 2024Drug	CLASS II	Cinacalcet Tablets 30 mg recalled by Accord HealthcareCinacalcet	Accord Healthcare	Nitrosamine Impurity	Nationwide
6 Nov 2024Drug	CLASS II	Cinacalcet Tablets, 60 mg recalled by Dr. Reddy's LaboratoriesCinacalcet	Dr. Reddy's Laboratories	Nitrosamine Impurity	Nationwide
6 Nov 2024Drug	CLASS II	Cinacalcet Tablets, 60 mg recalled by Accord HealthcareCinacalcet	Accord Healthcare	Nitrosamine Impurity	Nationwide
6 Nov 2024Drug	CLASS II	Cinacalcet Tablets, 90 mg recalled by Dr. Reddy's LaboratoriesCinacalcet	Dr. Reddy's Laboratories	Nitrosamine Impurity	Nationwide
6 Nov 2024Drug	CLASS II	Cinacalcet Tablets, 90 mg recalled by Accord HealthcareCinacalcet	Accord Healthcare	Nitrosamine Impurity	Nationwide
31 Jan 2024Drug	CLASS II	Cinacalcet Tablets 60mg recalled by Sun Pharmaceutical IndustriesCinacalcet	SUN Pharmaceutical Industries	Sterility	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.